If indeed PEDF represents an important regulatory node in the RASopathies, the effects of neurofibromin loss should be mitigated by PEDF restoration, and thus represent a potential adjuvant therapeutic strategy for NF1 melanoma. Here, NF1 is linked to neurofibromatosis type 1.